Literature DB >> 31967962

Cognitive impairments in type 2 diabetes, risk factors and preventive strategies.

Garima Sharma1, Arti Parihar2, Tanay Talaiya1, Kirti Dubey1, Bhagyesh Porwal1, Mordhwaj S Parihar3.   

Abstract

Mild cognitive impairment (MCI) is a modifiable risk factor in progression of several diseases including dementia and type 2 diabetes. If cognitive impairments are not reversed at an early stage of appearance of symptoms, then the prolonged pathogenesis can lead to dementia and Alzheimer's disease (AD). Therefore, it is necessary to detect the risk factors and mechanism of prevention of cognitive dysfunction at an early stage of disease. Poor lifestyle, age, hyperglycemia, hypercholesterolemia, and inflammation are some of the major risk factors that contribute to cognitive and memory impairments in diabetic patients. Mild cognitive impairment was seen in those individuals of type 2 diabetes, who are on an unhealthy diet. Physical inactivity, frequent alcohol consumptions, and use of packed food products that provides an excess of cheap calories are found associated with cognitive impairment and depression in diabetic patients. Omega fatty acids (FAs) and polyphenol-rich foods, especially flavonoids, can reduce the bad effects of an unhealthy lifestyle; therefore, the consumption of omega FAs and flavonoids may be beneficial in maintaining normal cognitive function. These functional foods may improve cognitive functions by targeting many enzymes and molecules in cells chiefly through their anti-inflammatory, antioxidant, or signaling actions. Here, we provide the current concepts on the risk factors of cognitive impairments in type 2 diabetes and the mechanism of prevention, using omega FAs and bioactive compounds obtained from fruits and vegetables. The knowledge derived from such studies may assist physicians in managing the health care of patients with cognitive difficulties.

Entities:  

Keywords:  age; hyperglycemia; mild cognitive impairment; omega fatty acids; polyphenols; unhealthy life style

Mesh:

Year:  2020        PMID: 31967962     DOI: 10.1515/jbcpp-2019-0105

Source DB:  PubMed          Journal:  J Basic Clin Physiol Pharmacol        ISSN: 0792-6855


  10 in total

Review 1.  Perioperative Neurocognitive Screening Tools for At-Risk Surgical Patients.

Authors:  Lilia Kaustov; Andrew Fleet; Connor T A Brenna; Beverley A Orser; Stephen Choi
Journal:  Neurol Clin Pract       Date:  2022-02

2.  Low serum apelin levels are associated with mild cognitive impairment in Type 2 diabetic patients.

Authors:  Yongli Jiang; Shidi Wang; Xinghui Liu
Journal:  BMC Endocr Disord       Date:  2022-05-24       Impact factor: 3.263

3.  The Association Between Plasma Fatty Acid and Cognitive Function Mediated by Inflammation in Patients with Type 2 Diabetes Mellitus.

Authors:  Jingyi Shen; Huiyan Yu; Kaifeng Li; Bingjie Ding; Rong Xiao; Weiwei Ma
Journal:  Diabetes Metab Syndr Obes       Date:  2022-05-06       Impact factor: 3.249

Review 4.  Polyphenols and Cognition In Humans: An Overview of Current Evidence from Recent Systematic Reviews and Meta-Analyses.

Authors:  Daniel Joseph Lamport; Claire Michelle Williams
Journal:  Brain Plast       Date:  2021-02-09

Review 5.  The Interplay between Diabetes and Alzheimer's Disease-In the Hunt for Biomarkers.

Authors:  Adriana Kubis-Kubiak; Aleksandra Dyba; Agnieszka Piwowar
Journal:  Int J Mol Sci       Date:  2020-04-15       Impact factor: 5.923

6.  The imbalance of PGD2-DPs pathway is involved in the type 2 diabetes brain injury by regulating autophagy.

Authors:  Yang Yang; Pu Xiang; Qi Chen; Ying Luo; Hong Wang; Huan Li; Lu Yang; Congli Hu; Jiahua Zhang; Yuke Li; Hui Xia; Zhihao Chen; Junqing Yang
Journal:  Int J Biol Sci       Date:  2021-09-21       Impact factor: 6.580

7.  Factors related to cognitive function in type-2 diabetes and neuropathic pain patients, the role of mood and sleep disorders in this relationship.

Authors:  Jenifer Palomo-Osuna; María Dueñas; Cristina Naranjo; Helena De Sola; Alejandro Salazar; Inmaculada Failde
Journal:  Sci Rep       Date:  2022-09-14       Impact factor: 4.996

8.  Associations of Age at Diagnosis and Duration of Diabetes With Morbidity and Mortality Among Older Adults.

Authors:  Christine T Cigolle; Caroline S Blaum; Chen Lyu; Jinkyung Ha; Mohammed Kabeto; Judy Zhong
Journal:  JAMA Netw Open       Date:  2022-09-01

9.  Fisetin Prevents HT22 Cells From High Glucose-Induced Neurotoxicity via PI3K/Akt/CREB Signaling Pathway.

Authors:  Shenshen Zhang; Ran Xue; Yaping Geng; Hao Wang; Wenjie Li
Journal:  Front Neurosci       Date:  2020-03-19       Impact factor: 4.677

10.  Multi-Omics Characterization of Type 2 Diabetes Mellitus-Induced Cognitive Impairment in the db/db Mouse Model.

Authors:  Xiaoxuan Song; Zeyu Zhu; Xiaohang Qian; Xiaoli Liu; Shengdi Chen; Huidong Tang
Journal:  Molecules       Date:  2022-03-15       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.